Published in Med Oncol on December 01, 1998
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia (2006) 3.54
The first national public breast cancer screening program in Saudi Arabia. Ann Saudi Med (2010) 1.39
Protein expression profile and prevalence pattern of the molecular classes of breast cancer--a Saudi population based study. BMC Cancer (2010) 1.04
Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women. Breast Cancer Res Treat (2008) 1.04
The incidence rate of female breast cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001-2008. Breast Cancer (Dove Med Press) (2013) 0.95
A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. BMC Cancer (2007) 0.94
Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients. Diagn Pathol (2011) 0.83
Systematic review of breast cancer biology in developing countries (part 1): Africa, the middle East, eastern europe, Mexico, the Caribbean and South america. Cancers (Basel) (2011) 0.79
Outcome as a measure of quality of care in oncology: experience at sultan qaboos university hospital, oman. Sultan Qaboos Univ Med J (2008) 0.79
Pre-operative systemic therapy in locally advanced breast cancer: a single institution experience. Ecancermedicalscience (2009) 0.75
Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis. Int J Cancer (2016) 0.75
Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. Ann Intern Med (1985) 1.84
Electronic clinical trial protocol distribution via the World-Wide Web: a prototype for reducing costs and errors, improving accrual, and saving trees. J Am Med Inform Assoc (1997) 1.41
Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: clinical features, management, and prognosis of 66 patients. Ann Oncol (2001) 1.34
Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncol (1999) 1.33
Extraskeletal Ewing's sarcoma family of tumours in adults: analysis of 57 patients from a single institution. Clin Oncol (R Coll Radiol) (2010) 1.25
Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol (1986) 1.24
Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol (1992) 1.21
Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med (1986) 1.14
Platelet function studies in human beings receiving 300 mg. of aspirin per day. J Lab Clin Med (1970) 1.14
Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Oncol (2000) 1.11
Some guidelines for heparin therapy of venous thromboembolic disease. JAMA (1967) 1.09
Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma. Ann Oncol (1999) 1.07
Tumor-promoting phorbol esters stimulate hematopoietic colony formation in vitro. Science (1980) 1.05
Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization. Bone Marrow Transplant (2010) 1.04
Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients. Head Neck (2001) 1.03
Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor. J Lab Clin Med (1974) 0.98
Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma. Am J Clin Oncol (2001) 0.96
Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously. J Natl Cancer Inst (1991) 0.96
Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization. Bone Marrow Transplant (2010) 0.96
Activity of trifluorothymidine against cytomegalovirus. Antimicrob Agents Chemother (1981) 0.94
Antigenic analysis of hematopoiesis. I. Expression of the My-1 granulocyte surface antigen on human marrow cells and leukemic cell lines. Blood (1983) 0.93
Platelet aggregation in patients with Laennec's cirrhosis of the liver. N Engl J Med (1967) 0.93
Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol (2000) 0.92
Pseudomonas aeruginosa exotoxin A inhibits proliferation of human bone marrow progenitor cells in vitro. Infect Immun (1982) 0.92
Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation. Antimicrob Agents Chemother (1983) 0.92
Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res (1987) 0.91
Growth factor plus preemptive ('just-in-time') plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure. Bone Marrow Transplant (2012) 0.90
Case report: isoimmune inhibition of erythropoiesis following ABO-incompatible bone marrow transplantation. Am J Med Sci (1991) 0.89
Tumor-promoting phorbol esters stimulate myelopoiesis and suppress erythropoiesis in cultures of mouse bone marrow cells. Proc Natl Acad Sci U S A (1981) 0.89
Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood (1985) 0.88
Bilateral angiosarcoma of the breast--a case report. Jpn J Surg (1991) 0.88
Dye-mediated photolysis of normal and neoplastic hematopoietic cells. Leuk Res (1987) 0.87
Regulation of hematopoiesis: helper and suppressor influences of the thymus. Blood (1980) 0.85
S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma. J Pathol (2008) 0.85
Tuberculosis in patients with malignant disease. Indian J Cancer (1989) 0.85
Evidence-based medicine for the new millennium: Critical appraisal and pragmatic approach. Ann Saudi Med (2007) 0.84
The influence of serum tumor necrosis factor-alpha and interleukin-6 concentrations on nonhematologic toxicity and hematologic recovery in patients with acute myelogenous leukemia. Exp Hematol (1995) 0.83
Regulation of myelopoiesis in vitro: partial replacement of colony-stimulating factors by tumor-promoting phorbol esters. Blood (1981) 0.83
Hematologic and cytogenetic remission of 5q-refractory anemia after syngeneic bone marrow transplantation. Am J Med (1986) 0.83
Effect of temperature and salinity changes on the blood characteristics of Tilapia zilli G. in Egyptian littoral lakes. Comp Biochem Physiol A Comp Physiol (1973) 0.83
Turcot syndrome: report of a case and review of the literature. Int Surg (1989) 0.82
Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma. Transplant Proc (2003) 0.81
Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study. Am J Med (1980) 0.81
Disposition of folic acid and its metabolites: a comparison with leucovorin. Clin Pharmacol Ther (1994) 0.81
Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Med Oncol (1997) 0.81
Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors. Clin Cancer Res (1999) 0.81
Monitoring heparin therapy with the activated partial thromboplastin time. Can Med Assoc J (1971) 0.80
The occurrence of a peripheral T-cell lymphoma in a chronically immunosuppressed renal transplant patient. Am J Surg Pathol (1988) 0.80
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial. Med Oncol (2000) 0.80
Medical therapy of prostate cancer. J S C Med Assoc (1994) 0.79
High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin. Breast Cancer Res Treat (2000) 0.79
Energy requirements of parenterally fed bone marrow transplant recipients. JPEN J Parenter Enteral Nutr (1985) 0.78
Transfusion management of an IgA deficient patient with anti-IgA and incidental correction of IgA deficiency after allogeneic bone marrow transplantation. Am J Hematol (1998) 0.78
Nutritional assessment by isotope dilution analysis of body composition. Am J Clin Nutr (1984) 0.78
Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor. Bone Marrow Transplant (2000) 0.78
Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells. Cancer Chemother Pharmacol (1990) 0.78
Platelet survival in patients with prosthetic heart valves. Am J Cardiol (1974) 0.77
Comparative effects o ADP and thrombin in producing stasis thrombosis. Thromb Diath Haemorrh (1967) 0.77
Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines. Cancer Res (1991) 0.77
Activation of intravascular coagulation by collagen. Proc Soc Exp Biol Med (1966) 0.77
Regulation of cyclic AMP levels and aggregation in human platelets by prostaglandin E . J Lab Clin Med (1973) 0.76
Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide. Exp Hematol (1985) 0.76
Consultation letters as a method for assessing in-training performance in a department of medicine. Eval Health Prof (1988) 0.76
Tumor-promoting phorbol esters support the in vitro proliferation of murine pluripotent hematopoietic stem cells. J Clin Invest (1989) 0.75
Editorial: Hypercoagulability--1974. Can Med Assoc J (1974) 0.75
Insensitivity of actin FS in the detection of nonspecific inhibitors. Arch Pathol Lab Med (1994) 0.75
Breast cancer. Trans Assoc Life Insur Med Dir Am (1989) 0.75
In vitro synergism of 4-hydroperoxycyclophosphamide and cisplatin: relevance for bone marrow purging. Cancer Chemother Pharmacol (1989) 0.75
Seasonal histological changes in the ovary of Sparus aurata, a hermaphrodite teleost marine fish (family: Sparidae). Folia Morphol (Praha) (1987) 0.75
Cytological and cytochemical changes in the ovary of Sparus aurata during the annual reproductive cycle. Folia Morphol (Praha) (1987) 0.75
Spermatogenesis in the marine hermaphrodite teleost fish Sparus aurata. Folia Morphol (Praha) (1987) 0.75
Seasonal changes in the cytology and cytochemistry of the pituitary gland of Sparus aurata. Folia Morphol (Praha) (1987) 0.75
Cyclic histological changes in the pituitary gland of Sparus aurata in correlation to the gonadal cycle. Folia Morphol (Praha) (1988) 0.75
Determination of sulphinpyrazone in patient plasma by gas chromatography. Thromb Res (1978) 0.75
Phorbol ester-stimulated murine myelopoiesis: role of colony-stimulating factors. J Cell Physiol (1983) 0.75
A new design for randomized trials. N Engl J Med (1979) 0.75
Synergism between 4-hydroperoxycyclophosphamide and cisplatin: importance of incubation sequence and measurement of cisplatin accumulation. Biochem Pharmacol (1990) 0.75
Effects of aspirin and sulfinpyrazone on platelet prostaglandin synthesis. Adv Exp Med Biol (1977) 0.75
Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update. Prog Clin Biol Res (1990) 0.75
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study. Cancer (1990) 0.75
Cytological and cytochemical seasonal changes in the testis of the marine hermaphrodite fish Sparus aurata. Folia Morphol (Praha) (1987) 0.75
Carcinoma of the cervix in a pregnant woman with negative Pap smears and colposcopic examination. Acta Obstet Gynecol Scand (1990) 0.75
Biochemical studies on the lipid content of Tilapia nilotica and Sparus auratus. Comp Biochem Physiol B (1984) 0.75
Adverse effects of nutritional deprivation on transplanted hematopoietic cells. Exp Hematol (1979) 0.75
Seasonal changes in the testis of the marine teleost fish Sparus aurata. Folia Morphol (Praha) (1987) 0.75
Delayed multiple toxic reactions possibly related to valproate therapy in a Saudi patient. Ann Saudi Med (1994) 0.75
Epinephrine potentiation of platelet aggregation: its effect on death from experimental pulmonaryeembolism. J Lab Clin Med (1968) 0.75
Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin's lymphoma in Saudi Arabia: clinical results and analysis of prognostic factors. Acta Haematol (1996) 0.75
Seasonal histological changes in the pituitary gland of Sparus aurata. Folia Morphol (Praha) (1987) 0.75
Abnormal fatty acid breath tests in cancer patients, with nutritional correlation. Cancer (1982) 0.75
Significant elevation of protein C and protein S levels in thrombotic disorders by low dose danazol. Blood Coagul Fibrinolysis (1991) 0.75
Immunotherapy of acute myeloid leukemia. Curr Pharm Biotechnol (2001) 0.75
CD34+ and CD33+ stem cells: predictors of hematologic recovery? Prog Clin Biol Res (1992) 0.75
Biometric studies on Epinephelus aeneus (G. Saint Hilaire) and Epinephelus alexandrinus (Valenciennes) (Serranidae) in Egyptian Mediterranean waters. Folia Morphol (Praha) (1985) 0.75
Fatty acid breath test values in the malabsorption range in cancer patients. Nutr Cancer (1982) 0.75
Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer. Rev Infect Dis (1982) 0.75
Loss to follow-up of patients with malignant lymphoma. Eur J Cancer Care (Engl) (2004) 0.75